查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球內視鏡黏膜下剝離術 (ESD) 市場（按產品、適應症、最終用戶和地區分類）- 預測至 2030 年
市場調查報告書
商品編碼
1807077

全球內視鏡黏膜下剝離術 (ESD) 市場（按產品、適應症、最終用戶和地區分類）- 預測至 2030 年

Endoscopic Submucosal Dissection/ESD Market by Product, Indication, End User - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 235 Pages | 訂單完成後即時交付

價格

內視鏡黏膜下剝離術市場預計將從 2025 年的 5 億美元成長到 2030 年的 7.5 億美元，預測期內的複合年成長率為 8.4%。

調查範圍
調查年份 2024-2030
基準年 2024
預測期 2025-2030
對價單位 金額（十億美元）
部分 按產品、適應症、最終用戶和地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲、海灣合作理事會國家

內視鏡黏膜下層剝離術 (ESD) 工具的技術進步顯著提高了此手術的臨床效用和安全性，從而推動了市場的成長。諸如混合刀等創新技術，結合了注射和切割功能，簡化了剝離流程，縮短了手術時間。此外，牽引輔助系統提高了黏膜下層的可視性和可及性，使複雜的剝離操作更易於操作。

內視鏡黏膜下剝離術/ESD市場-IMG1

高解析度和窄頻成像 (NBI) 內視鏡進一步提升了病變檢測和邊緣評估，從而提高了手術準確性並改善了患者預後。奧林巴斯和富士膠片等公司正在大力投資平台特定的創新，這些創新整合了能量輸送系統、符合人體工學的內視鏡設計和基於人工智慧的可視化輔助技術。

這些進展正在降低傳統上與ESD相關的技術障礙，使其在非學術環境和社區醫療保健領域中廣泛應用。隨著這些工具變得更加直覺和標準化，它們將促進新從業人員的學習過程，最終使ESD更容易獲得，並成為全球範圍內治療早期胃腸道腫瘤的首選方法。

內視鏡黏膜下剝離術 (ESD) 市場按產品類型細分為胃鏡及內視鏡、手術刀、注射劑、組織牽開器、抓夾和其他產品。預計到 2024 年，胃鏡及內視鏡將佔據全球 ESD 市場的最大佔有率。

高清 (HD) 和 4K 超高清 (UHD) 成像技術的最新進展，透過提供卓越的光學清晰度和精細的可視化效果，徹底改變了內視鏡黏膜下剝離 (ESD) 手術。窄帶成像 (NBI)、放大內視鏡和 4K 內視鏡等功能顯著提高了病灶檢測、邊緣可視化和整體手術準確性。這些影像增強功能降低了診斷錯誤的可能性，並實現了更精確的解剖，最終改善了患者的預後。因此，胃鏡和內視鏡在這些技術進步中發揮了關鍵作用，並因其對手術成功的關鍵貢獻，在 ESD 領域佔據了市場佔有率。

根據適應症，ESD 市場分為三個部分：胃癌、結腸癌和食道癌。 2024 年，胃癌佔據了 ESD 市場的最大佔有率。強力的臨床證據支持 ESD 作為治療胃黏膜和淺層黏膜下腫瘤的黃金標準。長期研究表明，ESD 可實現較高的整塊切除率、最小的局部復發率和極佳的器官保存效果，尤其與傳統手術相比。這些結果對於早期胃癌尤其重要，因為早期胃癌患者更希望獲得無需大手術的根治性方法。因此，由於 ESD 在胃部病變治療中強大的臨床檢驗和較高的手術成功率，胃癌領域在 ESD 市場中處於領先地位。

預計亞太地區將在預測期內佔據ESD市場的最大佔有率。日本和韓國政府資助的篩檢計畫正在積極推廣透過內視鏡檢查早期發現胃部和結腸直腸病變，從而顯著增加了ESD的實施量。該地區在採用先進醫療技術以加強患者護理和安全方面也處於領先地位。

本報告研究了全球內視鏡黏膜下剝離術/ESD 市場，按產品、適應症、最終用戶和地區對其進行細分，並提供了參與市場的公司概況。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章重要考察

第5章市場概述

  • 介紹
  • 市場動態
  • 產業趨勢
  • 監管分析
  • 市場生態系統
  • 價值鏈分析
  • 波特五力分析
  • 定價分析
  • 專利分析
  • 供應鏈分析
  • 2025年主要會議和活動
  • 主要相關人員和採購標準
  • 影響客戶業務的趨勢/中斷
  • 貿易分析
  • 技術分析
  • 內視鏡黏膜下剝離術市場：鄰近市場
  • 案例研究分析
  • 人工智慧/產生人工智慧對內視鏡黏膜下剝離術市場的影響
  • 2025年美國關稅對內視鏡黏膜下剝離術市場的影響
  • 投資金籌措場景

6. 內視鏡黏膜下剝離術市場（依產品）

  • 介紹
  • 胃鏡和大腸鏡
  • 刀
  • 注射
  • 組織牽開器
  • 抓鉗/夾子
  • 其他

7. 內視鏡黏膜下剝離術市場（依適應症）

  • 介紹
  • 胃癌
  • 大腸直腸癌
  • 食道癌

8. 內視鏡黏膜下剝離術市場（依最終用戶）

  • 介紹
  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

9. 內視鏡黏膜下剝離術市場（按地區）

  • 介紹
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 拉丁美洲
    • 購買力和醫療保健負擔能力的提高將推動市場成長
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 醫療基礎設施的進步增加了對醫院設施和醫療設備的需求
    • 中東和非洲宏觀經濟展望
  • 海灣合作理事會國家
    • 醫療基礎設施投資的增加和醫療旅遊的擴張將推動市場成長
    • 海灣合作理事會國家的宏觀經濟展望

第10章 競爭格局

  • 概述
  • 主要參與企業的策略/優勢
  • 收益分析
  • 市場佔有率分析
  • 公司估值矩陣：2024 年關鍵參與企業
  • 公司估值矩陣：Start-Ups/中小企業，2024 年
  • 估值和財務指標
  • 品牌/產品比較
  • 競爭場景

第11章 公司簡介

  • 主要參與企業
    • OLYMPUS CORPORATION
    • MEDTRONIC
    • FUJIFILM HOLDINGS CORPORATION
    • BOSTON SCIENTIFIC CORPORATION
    • SUMITOMO BAKELITE CO., LTD.
    • CREO MEDICAL GROUP PLC
    • HOYA CORPORATION
    • CONMED CORPORATION
    • STERIS
    • MTW ENDOSKOPIE MANUFAKTUR
    • OVESCO ENDOSCOPY AG
    • ZEON MEDICAL INC.
    • MICRO-TECH ENDOSCOPY
    • KARL STORZ SE & CO. KG
    • COOK MEDICAL
  • 其他公司
    • LEO MEDICAL CO., LTD.
    • ERBE ELEKTROMEDIZIN GMBH
    • TAEWOONG MEDICAL CO., LTD.
    • DCC HEALTHCARE
    • KOSSEN CO., LTD.
    • INNOVAMEDICA SPA
    • JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
    • HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.
    • BEIJING ZKSK TECHNOLOGY CO., LTD.
    • UPEX-MED CO., LTD.

第12章 附錄

Product Code: MD 8538

The endoscopic submucosal dissection market is projected to reach USD 0.75 billion by 2030 from USD 0.50 billion in 2025, at a CAGR of 8.4% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsProduct, Indication, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries

Technological advancements in endoscopic submucosal dissection (ESD) tools are significantly enhancing the procedure's clinical utility and safety, which, in turn, is driving market growth. Innovations such as hybrid knives that combine both injection and cutting capabilities have streamlined the dissection process and reduced procedural time. Additionally, traction-assisted systems have improved visualization and access to submucosal layers, making complex dissections more manageable.

Endoscopic Submucosal Dissection/ESD Market - IMG1

High-definition and narrow-band imaging (NBI) endoscopes have further enhanced the detection of lesions and assessment of margins, resulting in increased procedural accuracy and better patient outcomes. Companies like Olympus and Fujifilm are heavily investing in platform-specific innovations, integrating energy delivery systems, ergonomic endoscope designs, and AI-based visualization aids.

These developments are reducing the technical barriers traditionally associated with ESD, enabling broader adoption in non-academic and community healthcare settings. As these tools become more intuitive and standardized, they are facilitating the learning process for new practitioners, ultimately making ESD more accessible and preferred for the management of early-stage gastrointestinal tumors worldwide.

By product, the gastroscopes & endoscopes segment accounted for the largest share of the market in 2024.

The market for endoscopic submucosal dissection (ESD) is categorized by product type into gastroscopes & endoscopes, knives, injection agents, tissue retractors, grasping clips, and other products. In 2024, the segment for gastroscopes & endoscopes held the largest share of the global ESD market.

Recent advancements in high-definition (HD) and 4K ultra-high-definition (UHD) imaging technologies have transformed ESD procedures by providing superior optical clarity and detailed visualization. Features such as narrow-band imaging (NBI), magnification endoscopy, and 4K scopes significantly enhance the detection of lesions, delineation of margins, and overall procedural accuracy. These imaging enhancements reduce the likelihood of diagnostic errors and allow for more precise dissection, ultimately leading to improved patient outcomes. Consequently, gastroscopes & endoscopes play a vital role in these advancements, which is why they dominate the market share in the ESD sector, driven by their essential contribution to the success of these procedures.

Based on indications, the stomach cancer segment dominated the ESD market in 2024.

Based on indications, the ESD market is divided into three categories: stomach cancer, colon cancer, and esophageal cancer. In 2024, stomach cancer accounted for the largest share of the ESD market. Strong clinical evidence supports ESD as the gold standard for treating mucosal and superficial submucosal gastric tumors. Long-term studies have shown that ESD achieves high rates of en bloc resection, minimal local recurrence, and excellent organ preservation, especially when compared to traditional surgery. These outcomes are particularly significant for early-stage stomach cancers, where a curative approach without major surgery is preferred. Consequently, the stomach cancer segment leads the ESD market, driven by strong clinical validation and high procedural volumes in the management of gastric lesions.

Based on region, the Asia Pacific held the largest market share in 2024.

The Asia Pacific region is projected to hold the largest share of the ESD market during the forecast period. Government-funded screening programs in Japan and South Korea are actively promoting the early detection of gastric and colorectal lesions through endoscopy, which has significantly increased ESD volumes. This region has also been at the forefront of adopting advanced medical technology to enhance patient care and safety.

A breakdown of the primary participants (supply side) for the endoscopic submucosal dissection market referred to in this report is provided below:

  • By Company Type: Tier 1 (34%), Tier 2 (38%), and Tier 3 (28%)
  • By Designation: C-level Executives (26%), Directors (35%), and Others (39%)
  • By Region: North America (17%), Europe (39%), Asia Pacific (28%), Latin America (8%), Middle East & Africa (3%), and GCC Countries (5%)

Prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), FUJIFILM Holdings Corporation (Japan), Medtronic (Ireland), Boston Scientific Corporation (US), and Sumitomo Bakelite Co., Ltd. (Japan).

Research Coverage

The report assesses the endoscopic submucosal dissection market, estimating its size and future growth potential across various segments, including products, indications, end users, and regions. Additionally, the report features a competitive analysis of key players in the market, along with company profiles, product offerings, recent developments, and essential market strategies.

Reasons to Buy the Report

The report will provide valuable data on revenue estimates for the overall endoscopic submucosal dissection market and its subsegments, benefiting both market leaders and new entrants. It will help stakeholders understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report will give stakeholders insights into market trends, including key drivers, challenges, restraints, and opportunities.

This report provides insights into the following points:

  • Analysis of key drivers (increasing use of endoscopy in detection and treatment procedures and rising prevalence of cancer), restraints (dearth of skilled professionals and high overhead cost of ESD procedures with limited reimbursements), opportunities (growing demand for minimally invasive procedures, growing investments in R&D of endoscopy technology, and expected increase in adoption of and preference for ESD procedures in developing countries), and challenges (higher rate of complications and risk of post-operative infections).
  • Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global ESD market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, indication, end user, and region.
  • Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global ESD market.
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global ESD market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS COVERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY USED
  • 1.6 STAKEHOLDERS
  • 1.7 LIMITATIONS
  • 1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 METHODOLOGY-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT AND COUNTRY
  • 4.3 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC MIX
  • 4.4 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION
  • 4.5 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEVELOPED VS. DEVELOPING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing use of endoscopy in detection and treatment procedures
      • 5.2.1.2 Rising prevalence of cancer
      • 5.2.1.3 Growing geriatric population
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Dearth of skilled professionals
      • 5.2.2.2 High overhead cost of ESD procedures with limited reimbursements
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for minimally invasive procedures
      • 5.2.3.2 Expected increase in adoption of and preference for ESD procedures in developing countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Higher rate of complications
      • 5.2.4.2 Risk of post-operative infection
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 ADVANCES IN TRACTION METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION
    • 5.3.2 ROBOT-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION
  • 5.4 REGULATORY ANALYSIS
    • 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.4.2 REGULATORY LANDSCAPE
      • 5.4.2.1 North America
        • 5.4.2.1.1 US
        • 5.4.2.1.2 Canada
      • 5.4.2.2 Europe
        • 5.4.2.2.1 Germany
        • 5.4.2.2.2 France
        • 5.4.2.2.3 UK
        • 5.4.2.2.4 Italy
  • 5.5 MARKET ECOSYSTEM
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
      • 5.7.1.1 High capital requirement
      • 5.7.1.2 High preference for products from well-established brands
    • 5.7.2 THREAT OF SUBSTITUTES
      • 5.7.2.1 Presence of substitute therapies for endoscopic submucosal dissection
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
      • 5.7.3.1 Presence of several raw material suppliers
      • 5.7.3.2 Supplier switching cost
    • 5.7.4 BARGAINING POWER OF BUYERS
      • 5.7.4.1 Limited number of companies offering premium products at global level
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
      • 5.7.5.1 Increasing demand for high-quality and innovative products
      • 5.7.5.2 Lucrative growth potential in emerging markets
  • 5.8 PRICING ANALYSIS
    • 5.8.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2024
    • 5.8.2 AVERAGE SELLING PRICE TREND OF KNIVES, BY REGION, 2022-2024 (USD)
  • 5.9 PATENT ANALYSIS
  • 5.10 SUPPLY CHAIN ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS DURING 2025-2025
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.12.2 BUYING CRITERIA
  • 5.13 TRENDS/DISRUPTIONS AFFECTING CUSTOMER BUSINESS
    • 5.13.1 TRENDS/DISRUPTION IMPACTING CUSTOMER'S BUSINESS
  • 5.14 TRADE ANALYSIS
    • 5.14.1 IMPORT DATA
    • 5.14.2 EXPORT DATA
  • 5.15 TECHNOLOGY ANALYSIS
    • 5.15.1 KEY TECHNOLOGIES
      • 5.15.1.1 Endoscopic electrosurgical knives
      • 5.15.1.2 High-definition endoscopes
    • 5.15.2 COMPLEMENTARY TECHNOLOGIES
      • 5.15.2.1 Narrow band imaging/i-scan/FICE
      • 5.15.2.2 Optical coherence tomography (OCT)
    • 5.15.3 ADJACENT TECHNOLOGIES
      • 5.15.3.1 Endoscopic mucosal resection
      • 5.15.3.2 Full-thickness resection devices
  • 5.16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ADJACENT MARKET
  • 5.17 CASE STUDY ANALYSIS
    • 5.17.1 ROBOTIC-ASSISTED ESD FOR ESOPHAGEAL TUMORS
    • 5.17.2 COST-EFFECTIVE ESD DEVICES FOR STOMACH CANCER
    • 5.17.3 PRECISION ESD FOR COLORECTAL CANCER LESIONS
  • 5.18 IMPACT OF AI/GEN AI ON ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
    • 5.18.1 MARKET POTENTIAL OF AI IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
    • 5.18.2 AI USE CASES
    • 5.18.3 KEY COMPANIES IMPLEMENTING AI
    • 5.18.4 FUTURE OF GENERATIVE AI IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
  • 5.19 IMPACT OF 2025 US TARIFF ON ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
    • 5.19.1 KEY TARIFF RATES
    • 5.19.2 PRICE IMPACT ANALYSIS
    • 5.19.3 IMPACT ON END-USE INDUSTRIES
  • 5.20 INVESTMENT & FUNDING SCENARIO

6 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 GASTROSCOPES & COLONOSCOPES
    • 6.2.1 RISE IN COLON CANCER INCIDENCE TO DRIVE GROWTH
  • 6.3 KNIVES
    • 6.3.1 IMPROVED EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF KNIVES TO DRIVE MARKET GROWTH
  • 6.4 INJECTION AGENTS
    • 6.4.1 NEED FOR LOW-COST INJECTION AGENTS TO BOOST GROWTH
  • 6.5 TISSUE RETRACTORS
    • 6.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO AID ADOPTION
  • 6.6 GRASPERS/CLIPS
    • 6.6.1 PATIENT SAFETY AND HIGH PRECISION OFFERED BY GRASPERS TO DRIVE DEMAND
  • 6.7 OTHER PRODUCTS

7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION

  • 7.1 INTRODUCTION
  • 7.2 STOMACH CANCER
    • 7.2.1 SIGNIFICANT PROPORTION OF CANCER DEATHS TO DRIVE SEGMENT
  • 7.3 COLON CANCER
    • 7.3.1 INTEREST BY MEDICAL DEVICE MANUFACTURERS, CLINICAL INVESTIGATORS, AND PRACTICING CLINICIANS TO DRIVE MARKET
  • 7.4 ESOPHAGEAL CANCER
    • 7.4.1 GROWING PREVALENCE OF ESOPHAGEAL CANCER TO FUEL GROWTH

8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    • 8.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND ESD PROCEDURES TO SUPPORT GROWTH
  • 8.3 SPECIALTY CLINICS
    • 8.3.1 TRANSITION FROM HOSPITAL-BASED PROCEDURES TO CLINIC-BASED PROCEDURES TO BOOST GROWTH
  • 8.4 AMBULATORY SURGICAL CENTERS
    • 8.4.1 GROWTH IN SEGMENT DRIVEN BY INCREASING NUMBER OF OUTPATIENT VISITS
  • 8.5 OTHER END USERS

9 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 ASIA PACIFIC
    • 9.2.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.2.2 JAPAN
      • 9.2.2.1 Supportive medical device reimbursement policies to drive market growth
    • 9.2.3 CHINA
      • 9.2.3.1 Large patient population and strong need for healthcare infrastructure improvements to boost market growth
    • 9.2.4 INDIA
      • 9.2.4.1 Favorable government initiatives for healthcare infrastructure improvements to support market growth
    • 9.2.5 SOUTH KOREA
      • 9.2.5.1 Rapidly aging population and high incidence of gastrointestinal diseases to aid market growth
    • 9.2.6 AUSTRALIA
      • 9.2.6.1 High incidence of cancer to propel market growth
    • 9.2.7 REST OF ASIA PACIFIC
  • 9.3 NORTH AMERICA
    • 9.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.3.2 US
      • 9.3.2.1 Largest market for endoscopic submucosal dissection products
    • 9.3.3 CANADA
      • 9.3.3.1 Slower healthcare development over past decade to restrain growth
  • 9.4 EUROPE
    • 9.4.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.4.2 GERMANY
      • 9.4.2.1 Germany to account for largest share of European market
    • 9.4.3 FRANCE
      • 9.4.3.1 High-quality healthcare system offering coverage to all citizens to support market growth
    • 9.4.4 UK
      • 9.4.4.1 Investments by hospitals to purchase new and advanced endoscopic submucosal dissection equipment to propel market
    • 9.4.5 ITALY
      • 9.4.5.1 Receptivity of government toward high-quality and technologically advanced equipment to foster growth
    • 9.4.6 SPAIN
      • 9.4.6.1 Rising prevalence of cancer to drive market growth
    • 9.4.7 REST OF EUROPE
  • 9.5 LATIN AMERICA
    • 9.5.1 INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY TO FAVOR MARKET GROWTH
    • 9.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.3 BRAZIL
      • 9.5.3.1 Increase in private healthcare investments and rise in medical tourism to aid market growth
    • 9.5.4 MEXICO
      • 9.5.4.1 Increased government investment in healthcare infrastructure and technological advancements to aid market growth
    • 9.5.5 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 ADVANCEMENTS IN HEALTHCARE INFRASTRUCTURE TO CREATE NEED FOR HOSPITAL EQUIPMENT AND MEDICAL DEVICES
    • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.7 GCC COUNTRIES
    • 9.7.1 INCREASING INVESTMENT IN HEALTHCARE INFRASTRUCTURE AND GROWING MEDICAL TOURISM TO PROPEL MARKET GROWTH
    • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Product footprint
      • 10.5.5.4 Indication footprint
      • 10.5.5.5 End user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 10.6.5.1 Detailed list of key startups/SMEs
      • 10.6.5.2 Competitive benchmarking of key startups/SMEs
  • 10.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 10.7.1 FINANCIAL METRICS
    • 10.7.2 COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 OLYMPUS CORPORATION
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Deals
        • 11.1.1.3.2 Expansions
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses and competitive threats
    • 11.1.2 MEDTRONIC
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 MnM view
        • 11.1.2.3.1 Right to win
        • 11.1.2.3.2 Strategic choices
        • 11.1.2.3.3 Weaknesses and competitive threats
    • 11.1.3 FUJIFILM HOLDINGS CORPORATION
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches & approvals
        • 11.1.3.3.2 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses and competitive threats
    • 11.1.4 BOSTON SCIENTIFIC CORPORATION
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 MnM view
        • 11.1.4.3.1 Right to win
        • 11.1.4.3.2 Strategic choices
        • 11.1.4.3.3 Weaknesses and competitive threats
    • 11.1.5 SUMITOMO BAKELITE CO., LTD.
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 MnM view
        • 11.1.5.3.1 Right to win
        • 11.1.5.3.2 Strategic choices
        • 11.1.5.3.3 Weaknesses and competitive threats
    • 11.1.6 CREO MEDICAL GROUP PLC
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Deals
        • 11.1.6.3.2 Expansions
    • 11.1.7 HOYA CORPORATION
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
    • 11.1.8 CONMED CORPORATION
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
    • 11.1.9 STERIS
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Deals
    • 11.1.10 MTW ENDOSKOPIE MANUFAKTUR
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
    • 11.1.11 OVESCO ENDOSCOPY AG
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
    • 11.1.12 ZEON MEDICAL INC.
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
    • 11.1.13 MICRO-TECH ENDOSCOPY
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Product launches
    • 11.1.14 KARL STORZ SE & CO. KG
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
    • 11.1.15 COOK MEDICAL
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Product launches
  • 11.2 OTHER COMPANIES
    • 11.2.1 LEO MEDICAL CO., LTD.
    • 11.2.2 ERBE ELEKTROMEDIZIN GMBH
    • 11.2.3 TAEWOONG MEDICAL CO., LTD.
    • 11.2.4 DCC HEALTHCARE
    • 11.2.5 KOSSEN CO., LTD.
    • 11.2.6 INNOVAMEDICA S.P.A.
    • 11.2.7 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
    • 11.2.8 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.
    • 11.2.9 BEIJING ZKSK TECHNOLOGY CO., LTD.
    • 11.2.10 UPEX-MED CO., LTD.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
  • TABLE 3 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65-85+), 2020 VS. 2040
  • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ROLE IN ECOSYSTEM
  • TABLE 8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 9 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2024 (USD)
  • TABLE 10 AVERAGE SELLING PRICE TREND OF KNIVES, BY REGION, 2022-2024 (USD)
  • TABLE 11 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY PATENTS, 2023-2025
  • TABLE 12 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: CONFERENCES AND EVENTS, 2025-2026
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • TABLE 14 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 15 IMPORT DATA FOR HS CODE 901890 BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 16 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 17 TYPES OF ELECTROSURGICAL KNIVES: FEATURES & USE CASES
  • TABLE 18 KEY COMPANIES IMPLEMENTING AI
  • TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 20 KEY PRODUCT-RELATED TARIFFS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION
  • TABLE 21 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 22 GASTROSCOPES & COLONOSCOPES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 23 KNIVES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 24 KNIVES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2023-2030
  • TABLE 25 INJECTION AGENTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 26 INJECTION AGENTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2023-2030
  • TABLE 27 TISSUE RETRACTORS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 28 TISSUE RETRACTORS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2023-2030
  • TABLE 29 GRASPERS/CLIPS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 GRASPERS/CLIPS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2023-2030
  • TABLE 31 OTHER PRODUCTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 33 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2022 (NUMBER OF PROCEDURES)
  • TABLE 34 ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER, BY REGION (2022-2040)
  • TABLE 35 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY REGION, 2024 (NUMBER OF PROCEDURES)
  • TABLE 37 ESTIMATED NUMBER OF NEW CASES OF COLON CANCER, BY REGION (2022-2040)
  • TABLE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY REGION, 2024 (NUMBER OF PROCEDURES)
  • TABLE 40 ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2022-2040)
  • TABLE 41 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2024 (NUMBER OF PROCEDURES)
  • TABLE 43 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 44 HOSPITALS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 SPECIALTY CLINICS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 AMBULATORY SURGICAL CENTERS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 53 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 54 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 55 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 56 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 57 CHINA: MACROECONOMIC INDICATORS
  • TABLE 58 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 59 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 60 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 61 INDIA: MACROECONOMIC INDICATORS
  • TABLE 62 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 63 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 64 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 65 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 66 SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 67 SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 68 SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 69 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 70 AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 71 AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 72 AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 73 REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 74 REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 75 REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 79 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 80 US: MACROECONOMIC INDICATORS
  • TABLE 81 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 82 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 83 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 84 AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040
  • TABLE 85 CANADA: MACROECONOMIC INDICATORS
  • TABLE 86 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 87 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 88 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 89 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 90 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 91 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 92 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 93 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 94 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 95 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 96 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 97 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 98 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 99 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 100 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 101 UK: MACROECONOMIC INDICATORS
  • TABLE 102 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 103 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 104 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 105 ITALY: MACROECONOMIC INDICATORS
  • TABLE 106 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 107 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 108 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 109 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 110 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 111 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 112 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 113 REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 114 REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 115 REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 116 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 117 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 118 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 119 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 120 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 121 BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 122 BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 123 BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 124 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 125 MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 126 MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 127 MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 128 REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 129 REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 130 REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 131 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 132 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 133 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 134 GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 135 GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 136 GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 137 KEY DEVELOPMENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, JANUARY 2021-JUNE 2025
  • TABLE 138 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : DEGREE OF COMPETITION
  • TABLE 139 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : REGION FOOTPRINT
  • TABLE 140 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT FOOTPRINT
  • TABLE 141 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: INDICATION FOOTPRINT
  • TABLE 142 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: END USER FOOTPRINT
  • TABLE 143 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY STARTUPS/SMES
  • TABLE 144 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
  • TABLE 145 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT
  • TABLE 146 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
  • TABLE 147 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 148 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 149 OLYMPUS CORPORATION: BUSINESS OVERVIEW
  • TABLE 150 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 151 OLYMPUS CORPORATION: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 152 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 153 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 154 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 155 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
  • TABLE 156 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 157 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JUNE 2025
  • TABLE 158 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 159 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
  • TABLE 160 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 161 SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW
  • TABLE 162 SUMITOMO BAKELITE CO., LTD.: PRODUCTS OFFERED
  • TABLE 163 CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW
  • TABLE 164 CREO MEDICAL GROUP PLC: PRODUCTS OFFERED
  • TABLE 165 CREO MEDICAL GROUP PLC: DEALS, JANUARY 2021-JUNE 2025
  • TABLE 166 CREO MEDICAL GROUP PLC: EXPANSIONS, JANUARY 2021-JUNE 2025
  • TABLE 167 HOYA CORPORATION: BUSINESS OVERVIEW
  • TABLE 168 HOYA CORPORATION: PRODUCTS OFFERED
  • TABLE 169 CONMED CORPORATION: BUSINESS OVERVIEW
  • TABLE 170 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 171 STERIS: COMPANY OVERVIEW
  • TABLE 172 STERIS: PRODUCTS OFFERED
  • TABLE 173 STERIS: DEALS
  • TABLE 174 MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW
  • TABLE 175 MTW ENDOSKOPIE MANUFAKTUR: PRODUCTS OFFERED
  • TABLE 176 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW
  • TABLE 177 OVESCO ENDOSCOPY AG: PRODUCTS OFFERED
  • TABLE 178 ZEON MEDICAL INC.: BUSINESS OVERVIEW
  • TABLE 179 ZEON MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 180 MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW
  • TABLE 181 MICRO-TECH ENDOSCOPY: PRODUCTS OFFERED
  • TABLE 182 MICRO-TECH ENDOSCOPY: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
  • TABLE 183 KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW
  • TABLE 184 KARL STORZ SE & CO. KG.: PRODUCTS OFFERED
  • TABLE 185 COOK MEDICAL: BUSINESS OVERVIEW
  • TABLE 186 COOK MEDICAL: PRODUCTS OFFERED
  • TABLE 187 COOK MEDICAL: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
  • TABLE 188 LEO MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 189 ERBE ELEKTROMEDIZIN GMBH: COMPANY OVERVIEW
  • TABLE 190 TAEWOONG MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 191 DCC HEALTHCARE: COMPANY OVERVIEW
  • TABLE 192 KOSSEN CO., LTD.: COMPANY OVERVIEW
  • TABLE 193 INNOVAMEDICA S.P.A.: COMPANY OVERVIEW
  • TABLE 194 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 195 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 196 BEIJING ZKSK TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 197 UPEX-MED CO., LTD.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION
  • FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET (2024)
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025-2030)
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 12 TOP-DOWN APPROACH
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
  • FIGURE 18 INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH
  • FIGURE 19 GASTROSCOPES & COLONOSCOPES HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2024
  • FIGURE 20 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 21 ASIA PACIFIC TO BE LARGEST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
  • FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 GLOBAL CANCER INCIDENCE, 2022-2050
  • FIGURE 25 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 28 AVERAGE SELLING PRICE TREND OF KNIVES, BY REGION, 2022-2024 (USD)
  • FIGURE 29 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: TOP PATENT OWNERS/APPLICANTS AND NUMBER OF PATENTS GRANTED, JANUARY 2015-JUNE 2025
  • FIGURE 30 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: STAKEHOLDERS IN SUPPLY CHAIN
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 33 IMPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
  • FIGURE 34 EXPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
  • FIGURE 35 KEY FEATURES OF GEN AI IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
  • FIGURE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: FUNDING AND NUMBER OF DEALS, 2019-2023 (USD MILLION)
  • FIGURE 37 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
  • FIGURE 39 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
  • FIGURE 40 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF TOP PLAYERS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2020-2024 (USD MILLION)
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
  • FIGURE 43 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 44 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY FOOTPRINT
  • FIGURE 45 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 48 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 49 OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 50 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 51 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 52 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 53 SUMITOMO BAKELITE CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 54 CREO MEDICAL GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 55 HOYA CORPORATION: COMPANY SNAPSHOT
  • FIGURE 56 CONMED CORPORATION: COMPANY SNAPSHOT
  • FIGURE 57 STERIS: COMPANY SNAPSHOT